Viewing Study NCT00126867


Ignite Creation Date: 2025-12-25 @ 12:33 AM
Ignite Modification Date: 2026-02-22 @ 5:09 PM
Study NCT ID: NCT00126867
Status: TERMINATED
Last Update Posted: 2019-07-05
First Post: 2005-08-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Thymidylate Synthase Polymorphisms as a Predictor of Toxicity to Capecitabine Chemotherapy in Colon Cancer Treatment
Sponsor: AHS Cancer Control Alberta
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Colon Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None thymidylate synthase polymers View
None rapecitabine View
None adjuvant View
None colon cancer View
None toxicity View
None Stage II colon cancer View
None Stage III colon cancer View
None adenocarcinoma of the colon View